Metoprolol raise blood sugar
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol and Blood Sugar Levels: A Comprehensive Review
Introduction to Metoprolol and Blood Sugar
Metoprolol, a cardioselective beta-blocker, is commonly prescribed for managing hypertension and other cardiovascular conditions. However, its impact on blood sugar levels, particularly in diabetic and hypertensive patients, has been a subject of extensive research. This article synthesizes findings from multiple studies to provide a clear understanding of how metoprolol affects blood glucose levels.
Metoprolol and Blood Sugar Increase
Evidence from Clinical Studies
Several studies have demonstrated that metoprolol can lead to an increase in blood sugar levels. In a study comparing metoprolol and propranolol in hypertensive diabetic patients, both drugs were found to raise fasting, noon, and mid-afternoon blood sugar concentrations by 1.0-1.5 mmol/l (18-27 mg/100 ml) . Another study involving patients with diastolic hypertension reported that metoprolol treatment resulted in significant increases in both fasting blood glucose and 2-hour postprandial blood glucose levels .
Insulin Sensitivity and Glucose Metabolism
Metoprolol has also been shown to affect insulin sensitivity and glucose metabolism. A randomized, double-blind study comparing metoprolol and atenolol found that both drugs decreased glucose uptake mediated by insulin, indicating reduced insulin sensitivity. This was accompanied by small increases in fasting plasma insulin and blood glucose concentrations . Additionally, a study on hypertensive subjects revealed that metoprolol treatment led to higher plasma insulin levels during a hyperinsulinemic euglycemic clamp, suggesting decreased insulin sensitivity .
Comparative Effects with Other Beta-Blockers
Propranolol and Acebutolol
Comparative studies have shown that the effects of metoprolol on blood sugar are similar to those of other beta-blockers like propranolol. Both metoprolol and propranolol were found to potentiate insulin-induced hypoglycemia and delay the return to normoglycemia in healthy volunteers . However, in maturity-onset diabetics, neither metoprolol nor propranolol had a significant effect on fasting plasma glucose, glucose tolerance, or insulin response .
Atenolol
In the study comparing metoprolol and atenolol, both drugs caused similar metabolic abnormalities, including increased fasting plasma insulin and blood glucose concentrations. This suggests that the adverse effects on glucose metabolism are not unique to metoprolol but are a common feature of beta-blockers .
Clinical Implications and Recommendations
Monitoring and Management
Given the potential for metoprolol to raise blood sugar levels, it is crucial for healthcare providers to monitor blood glucose levels closely in patients, especially those with diabetes or at risk of developing diabetes. Regular monitoring can help in adjusting treatment plans to mitigate the risk of hyperglycemia Wright1979Wen-Ji2013.
Balancing Benefits and Risks
While metoprolol is effective in managing hypertension and reducing cardiovascular risk, its impact on blood sugar levels necessitates a careful balance between benefits and potential metabolic side effects. In some cases, alternative medications or additional treatments to manage blood glucose may be considered Pollare1989Gudbjörnsdottir1997.
Conclusion
Metoprolol, like other beta-blockers, can lead to increases in blood sugar levels and reduced insulin sensitivity. These effects are significant in both diabetic and hypertensive patients, necessitating careful monitoring and management. By understanding these impacts, healthcare providers can better tailor treatments to ensure both cardiovascular and metabolic health.
Sources and full results
Most relevant research papers on this topic